IP Cases — 2024
6,517 decisions across all jurisdictions
Page 88 of 218 · 6,517 total
Ilooda Co., Ltd. et al. v.Serendia, LLC
Endymed Medical and Serendia settled their inter partes review of U.S. Patent 9,480,836, leading the PTAB to terminate the proceeding under 35 U.S.C. § 317.
Ilooda Co., Ltd. et al. v.Serendia, LLC
The PTAB granted a joint motion to terminate the IPR for Jeisys Medical Inc. after the parties settled their dispute. The settlement agreement was ordered to be kept confidential, and the proceeding remains open only for EndyMed petitioners.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Ilooda and Serendia filed a joint motion to terminate Ilooda's participation in an IPR over a dermatology device patent, citing a settlement that resolves the dispute.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Jeisys Medical and Serendia have settled their dispute over U.S. Patent 9,480,836 and jointly moved to terminate the inter partes review. The Board is asked to end the proceeding before any substantive briefing or hearing.
Jeisys Medical Inc. et al. v.Serendia, LLC
Serendia and Jeisys Medical settled their IPR dispute over U.S. Patent 9,320,536, leading the PTAB to terminate the proceeding.
Jeisys Medical Inc. et al. v.Serendia, LLC
EndyMed Medical and Serendia, LLC jointly filed a request to keep their settlement agreement confidential under statutory provisions, separating it from the IPR file.
Jeisys Medical Inc. et al. v.Serendia, LLC
EndyMed Medical Ltd. and EndyMed Medical Inc. jointly moved to terminate IPR2024-00384 after reaching a settlement with patent owner Serendia, LLC. The Board was asked to end the proceeding before any oral hearing or final decision.
Jeisys Medical Inc. et al. v.Serendia, LLC
Serendia requests Director Review to terminate IPR2024-00384, arguing the Board improperly expedited institution of time‑barred petitions despite a pending ITC validity finding. The petition cites the rescinded Fintiv memo and extraordinary circumstances to seek dismissal.
Jeisys Medical Inc. et al. v.Serendia, LLC
Jeisys Medical and Serendia have settled their IPR dispute over U.S. Patent 9,320,536 and jointly moved to terminate the proceeding under 35 U.S.C. §317.
Jeisys Medical Inc. et al. v.Serendia, LLC
Ilooda and Serendia have settled their dispute over a dermatology‑device patent and jointly moved to terminate Ilooda’s participation in the pending IPR, requesting the settlement remain confidential.
Jeisys Medical Inc. et al. v.Serendia, LLC
Jeisys Medical and Serendia have jointly filed a request with the PTAB to keep their settlement agreement confidential under statutory confidentiality rules. The filing cites 35 U.S.C. §317(b) and related CFR provisions.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung Electronics and Advanced Coding Technologies have reached a confidential settlement over U.S. Patent 8,090,025 and jointly moved to terminate the inter partes review.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung and Advanced Coding Technologies settled their IPR dispute over patent 10,218,995. The Board granted the joint motion to terminate the proceeding and treated the settlement agreement as confidential.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung and video‑codec startup Advanced Coding Technologies have settled their dispute over a moving‑picture encoding patent, filing a joint motion to terminate the inter partes review.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia and EndyMed jointly filed a request to keep their settlement agreement confidential under federal law, seeking to separate it from the patent record.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia and Jeisys Medical jointly filed a request to keep their settlement agreement confidential under 35 U.S.C. §317(b), seeking to separate it from the patent record.
Jeisys Medical Inc. et al. v.Serendia, LLC
Jeisys Medical settled with SHEnB and Cartessa respondents during its IPR against Serendia, leading to a motion to suspend the schedule.
Jeisys Medical Inc. et al. v.Serendia, LLC
The Board granted a joint motion to terminate the IPR only for Jeisys Medical Inc. after a settlement with Serendia, while EndyMed remains as a petitioner. The settlement agreement was ordered confidential.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung and Advanced Coding Technologies settled their IPR dispute over patent 8,090,025, leading the PTAB to terminate the proceeding. The settlement agreement was treated as confidential business information.
Bowmar Archery LLC v.Futtere, Matthew
Bowmar Archery LLC successfully petitioned the PTAB to institute review of claims in Patent No. 8043177, challenging its validity based on anticipation and obviousness grounds. The petition cites numerous prior art references related to broadhead technology, arguing that the claimed structural elements are already known in the field.
AT&T Corp. et al. v.Daingean Technologies Ltd.
A coalition of major telecom companies (AT&T, Ericsson, Nokia, T-Mobile) filed a Petition challenging Daingean Technologies' patent 10841958. The challenge asserts that the claims are anticipated or obvious based on prior art references Lee and Brismar.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Petitioner Ilooda Co., Ltd. and Jeisys Medical Inc. challenged the validity of Serendia, LLC's '836 patent in a PTAB petition. The petitioner asserts that multiple claims are obvious under 35 U.S.C. § 103 based on combinations of prior art references like Ganz, Livneh, Hantash, and Lee.
Jeisys Medical Inc. et al. v.Serendia, LLC
Petitioner Jeisys Medical Inc. successfully petitioned the PTAB to institute review of U.S. Patent No. 9,320,536 regarding dermatological treatment devices. The petition asserts compelling grounds for unpatentability under both 35 U.S.C. §§ 102 and 103 based on multiple prior art references.
Jeisys Medical Inc. et al. v.Serendia, LLC
Jeisys Medical Inc. and Ilooda Co., Ltd. challenged U.S. Patent No. 9,320,536 in a petition asserting anticipation (102) and obviousness (103). The challengers argue that the patent's claims are rendered unpatentable by prior art references including Mehta, Na ’848, Lee, and Livneh.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung Electronics challenges U.S. Patent No. 8,090,025 regarding video coding and error concealment techniques via an IPR Petition. The petitioner asserts that all ten claims are obvious over combinations of prior art references including Mualla, Shirani, and Saito.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung filed a Petition challenging claims of the '995 Patent, arguing they are obvious in light of prior art including Phek, Segall, Martins, and He. The petitioner asserts that combining these video coding techniques renders the claimed features predictable to a POSITA.
Alertus Technologies, LLC v.Desktop Alert, Inc.
Alertus Technologies challenges the validity of Patent No. 9172765, arguing that all 13 claims are obvious under 35 U.S.C. § 103. The Petitioner relies heavily on combining prior art references, specifically Dillon and AAPA, with other relevant technical disclosures like Brady and Douglas to demonstrate obviousness in network communication protocols.
WIZ, Inc. v.Orca Security Ltd.
WIZ, Inc. filed a petition challenging Orca Security Ltd.'s patent via IPR, asserting that the claims are obvious over prior art references Veselov and Basavapatna. The petitioner argues that combining these two references teaches every limitation of the challenged cloud security claims.
AT&T Corp. et al. v.Daingean Technologies Ltd.
The PTAB instituted the IPR against Daingean Technologies Ltd., finding reasonable likelihood of prevailing on claims 1-4. The challenge centers on whether prior art (Lee et al. and Brismar et al.) anticipates or renders obvious the methods for managing System Information Blocks in wireless networks.
Bowmar Archery LLC v.Futtere, Matthew
Bowmar Archery LLC successfully challenged Matthew Futtere's patent (8043177) in the PTAB, leading to institution on grounds of anticipation and obviousness. The Board adopted key claim constructions while finding a reasonable likelihood of unpatentability for at least claim 11.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.